Global stents market estimated to reach USD 12.13 billion by 2022
As per a market research report published by Market Research Store, the global stents market registered revenue of USD 8.43 billion in 2015 and is expected to reach USD 12.13 billion by 2022 by growing at a compound annual growth rate of 5.3%. The major driving factors include espousal of drug-eluting stents as a more efficient alternative treatment for coronary heart disorders, coupled with rising level of cognizance among patients about stents. However, stern regulations for acquiescence of stents, inefficient reimbursement policies, and alternative surgical procedures may restrict the growth of the market. The bio-absorbable stents segment is poised to register the highest CAGR over the forecast period. Abbott Laboratories, Medtronic, and Boston Scientific are the three leading players of the global market followed by Arterius, B. Braun, Biosensors International, Biotronik, C.R. Bard, Celonova Biosciences, Cook Medical, Cordis, Elixir Medical, Inspiremd and Kyoto.